Schedule 13D ownership disclosure
REGENERON PHARMACEUTICALS COM
Security class unavailable · CUSIP: 75886F107
Event date: 2014-06-27
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 20,258,841
- Percent of class
- 20.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001140361-14-027105
- Form type
- SC 13D
- Filer
- REGENERON PHARMACEUTICALS, INC.
- CIK
- CIK 872589
- Filed
- Jul 01, 2014
- Reporting period
- Jun 27, 2014
- Description
- Schedule 13D beneficial ownership